/Join_Us.gif)
/Morrison_Foerster.gif)
/Clinical_trial_470_x_80_(new).gif)
Clinical Trials Update provides you with latest news about clinical trials conducted by MVA member companies. The update gives insight to progress in studies, results and possible indications.
Santaris Pharma begins human clinical testing of the world's first medicine targeted at a human microRNA
May 28 - Santaris Pharma have announced that it has commenced a Phase I human volunteer trial of the world's first microRNA medicine to be tested in man - SPC3649 (LNA-antimiRTM-122). SPC3649 is being developed by Santaris Pharma as a potential new approach to the treatment for Hepatitis C infection. Phase II studies in hepatitis C patients will follow.
Bavarian Nordic enters clinical trials with HIV multiantigen vaccine
27 May - Bavarian Nordic has initiated Phase I/II clinical study with its HIV vaccine candidate: MVA-BN HIV multiantigen. The first safety data are expected by the end of 2008, while the immunogenicity data will be available during first half of 2009.
